The proliferation of antibiotic-resistant viruses poses a growing threat to medicine

Matt Hancock warned that the proliferation of deadly viruses poses an even greater threat than Covid-19 and should be regarded as global warming.

Modern medicine, he said, could ‘cease to exist’ unless the ‘silent epidemic’ of antibiotic resistance is urgently addressed. Drug-resistant diseases like MRSA cause 700,000 deaths worldwide each year, including 5,000 in the UK.

However, experts fear the annual death toll could reach 10 million by 2050, with common infections like gonorrhea and E. coli having ‘learned to’ hide antibiotics.

Speaking at a United Nations conference, Mr. Hancock announced that No10 had donated an additional £ 1.3 million to a project backed by the World Health Organization, aimed at stopping the proliferation of the virus. .

He argued that Covid-19 was an example of how countries and health care from around the world could come together to fight an epidemic, while calling on governments for help.

“There has been a lot of progress against these deadly diseases thanks to the power and ingenuity of modern science and medicine,” he added. But if we fail to stop resistance, modern medicine as we know it may no longer exist.

And the AMR pandemic could have silently caused far more deadly consequences than Covid-19. In my opinion, it is an existential threat just as big as climate change ”.

The additional money will go to the Multi-Partner Trust Fund on the AMR, which funds research projects to create new drugs to fight the virus. The UK has paid £ 7.6m for the project since its launch in 2019, with £ 4.1m raised last year.

Matt Hancock urged countries against the emergence of antibiotic-resistant bacteria. Image of him injecting AstraZeneca at the Science Museum, London.

Antibiotic resistance (AMR) begins when bacteria, viruses, and fungi learn to survive with the drug. When exposed to too much of the drug, the bacteria have mutations that allow them to survive and reproduce. They pass this trait on to their offspring and over time this can lead to a complete line of drug resistance.

Matt Hancock also supports the UN’s call to action against nations to push this issue on the political agenda. He added: “On behalf of the UK government, I welcome and fully endorse the call to action on AMR, because we still have a lot to do together, learn from the lessons of the university. translate this quickly.

Working related to human, animal and environmental health to ensure that we deal with the next pandemic, so there will be modern medicine that everyone can benefit from today. now on”.

In a separate statement, the Minister of Health also revealed an additional £ 37 million investment in life sciences, as part of the Government’s vision to make the country a science superpower. Global.

Genomics England will receive a £ 17 million grant to support investment in research into new ways to diagnose cancer, using the human genome.

Funding will also be used to speed up clinical trials to find out how genetic changes can lead to serious illness.

Speaking at the British Pharmaceutical Industry Association’s annual meeting, Mr. Hancock said: “I am committed to making it quick and easy to set up and deliver high-capacity clinical trials. Since then, it will be put on the market safer and faster, be it cancer or heart disease, for every disease known to mankind.

Altogether, all of this will lead to better research, better treatment, more accurate clinical decisions, more lives saved and improved lives, that’s the mission. of life sciences ”.

Rapid clinical trials have produced several drugs that are immediately available to patients during the pandemic, including dexamethasone, which has shown a reduction in mortality in Covid-19 patients.

Huong Giang (Source: dailymail)



Leave a Reply

Your email address will not be published. Required fields are marked *